HomeMedical SpecialtiesSafe MedicationGender-affirming hormone therapy: What you need to know about medication safety

Gender-affirming hormone therapy: What you need to know about medication safety

Published on

Xander (they/them), a 22-year-old non-binary person assigned female at birth (AFAB), arrives at their local pharmacy with a new prescription: injectable testosterone cypionate, 50 mg IM (intramuscular) weekly. It’s an exciting milestone – Xander is finally starting gender-affirming hormone therapy (GAHT). But they’re also anxious about this new medication. “How should I inject this? Is there anything else I should know?”

This article is meant to help answer medication related questions just like Xander’s. Whether you’re starting GAHT, supporting a loved one, or a healthcare provider unfamiliar with gender-affirming care, it is important to understand medication safety aspects of hormone therapy.

Gender-Affirming Hormone Therapy (GAHT)

GAHT supports individuals in aligning their physical traits with their gender identity. GAHT can significantly reduce gender dysphoria, improve mental and physical well-being and may be used alone or alongside surgery and social transition. For some individuals, it also supports long-term health, such as preserving bone density after certain organ removals.

Before starting GAHT, discuss fertility preservation with your healthcare provider if future family planning is important to you. Many clinics use an informed consent model, where providers explain the benefits, risks, and what to expect from treatment while supporting the level of change that feels right for you – whether that is full or partial masculinization or feminization.

Types of GAHT

Feminizing Hormone Therapy is used by trans women and transfeminine or non-binary individuals. Estrogen, often combined with anti-androgens like spironolactone, encourages breast development, skin softening, and fat re-distribution. It comes in different dosage forms – oral (to be taken by mouth), patch (to be applied on skin), and injectable. Oral estrogens may carry a slightly higher risk of blood clots compared to patches or injections, but they are more affordable and commonly used. If you are concerned about the risks of blood clots associated with estrogen, discuss with your healthcare provider.

Masculinizing Hormone Therapy, or testosterone, is used by trans men and transmasculine or non-binary individuals. Testosterone deepens the voice, increases muscle mass, stops menstrual periods, increases libido, shifts fat distribution and body hair patterns. Testosterone is most often given as weekly intramuscular (IM) or subcutaneous (SC) injections, which are cost-effective and widely used. Gels and patches are alternative topical dosage forms for individuals who do not prefer needles or injections; however, topical dosage forms may transfer the medication to others through skin contact and cause unwanted masculinizing effects.

How should Xander inject the medication? After learning about the potential risks of topical transfer with gels or patches, Xander decides to stick with testosterone injections.

Safe Injection Practices

If you have not been formally trained with the use of injectable medications, ask your pharmacist or healthcare provider to walk you through the steps. Community clinics, public health units, and resources like Rainbow Health Ontario (https://www.rainbowhealthontario.ca/): A Guide to Self-administering Intramuscular or Subcutaneous Injections (https://www.rainbowhealthontario.ca/resource-library/a-guide-to-self-administering-intramuscular-or-subcutaneous-injections/) may also offer help and support.

When using injectable testosterone (or other injectable medications), safe medication use considerations are essential. For example:

• Always use a sterile needle and never re-use it. Dull needles will increase pain and infection risk.

• Draw up the medication with a wider needle (e.g., 18-gauge), then switch to a smaller one (e.g., 25-gauge) for injection to minimize pain and
scarring.

• Never share needles. This will increase the risk of infections (e.g., HIV and hepatitis).

• Dispose used needles in a sharps container. Many pharmacies and harm reduction programs offer free sharps disposal service.

Is there anything else Xander should know?

Medication Therapy Management/Monitoring

Hormones are powerful medications that require monitoring. Regular blood work helps track hormone levels and monitor liver function, cholesterol, red blood cell counts, etc. Based on your anatomy, you may also need cancer screenings like pap smears or mammograms. Let your healthcare provider know if you smoke or vape. Individualized care is key, especially during your transition.

Medication Shortages

Testosterone shortages are quite common. If a medication shortage occurs, avoid turning to unregulated or street-sourced hormones, which may be unsafe, contaminated, or improperly dosed. Instead, talk to your pharmacist about alternatives, such as compounded hormone therapies (see below). Supportive clinics may sometimes be able to offer temporary solutions.

Compounded Hormone Therapies

Some individuals use compounded estrogen or testosterone in dosage forms like customized gels or creams. These are prepared by specialty compounding pharmacies that are accredited and regulated by provincial pharmacy regulatory authorities (or Colleges). DIY or unverified hormonal products could be harmful and should be avoided.

By Mona Mollaeizadeh, Heather Amann, and Certina Ho

Mona Mollaeizadeh and Heather Amann are PharmD Students at the Leslie Dan Faculty of Pharmacy, University of Toronto; and Certina Ho is an Assistant Professor, Teaching Stream, at the Leslie Dan Faculty of Pharmacy and Department of Psychiatry, University of Toronto.

Latest articles

Clinical trial comparing methods of controlling bleeding in cardiac patients

Royal Columbian Hospital is one of 12 North American hospitals involved in a study...

Reducing waitlists for patients with heart valve disease

The Montreal Heart Institute recently opened the MHI’s Heart Valve Centre, a large-scale medical...

Gender bias holds back female surgeons, study finds

From ill-fitting instruments to assumptions about competence, surgical culture sidelines women, first Canadian study...

Melanoma Canada is proud to announce, the Mole Mobile.

Melanoma Canada is proud to announce, the Mole Mobile, mobile skin cancer screening unit on...

More like this

Clinical trial comparing methods of controlling bleeding in cardiac patients

Royal Columbian Hospital is one of 12 North American hospitals involved in a study...

Reducing waitlists for patients with heart valve disease

The Montreal Heart Institute recently opened the MHI’s Heart Valve Centre, a large-scale medical...

AI receptionist answers the call for busy medical clinics

Hospital patients/family members test drive AI phone software co-created by HHS doctor. A Hamilton Health...

World-first clinical trial confirms exercise improves survival for colon cancer

A groundbreaking clinical trial funded by the Canadian Cancer Society (CCS) shows that physical...

Botox at 40: From medical curiosity to a wide range of uses

Originating in a lab in San Francisco in the 1970s, botulinum toxin  –  best...

Canadian first: One-of-a-kind imaging platform for mental health

The Royal has received a $1.9 million grant from Brain Canada to launch a...